French Publish Industry Guide To Reporting Non-Approved Uses Of Medicines
This article was originally published in SRA
Executive Summary
Pharmaceutical companies in France wanting to know how to report cases of medicines being prescribed outside their approved conditions of use now have a handy guide to doing so, courtesy of the regulatory agency, the Agence Nationale de la Sécurité du Médicament et des produits de santé (ANSM)1.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.